dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T13:24:53Z
dc.date.accessioned2022-10-05T13:15:08Z
dc.date.available2014-05-20T13:24:53Z
dc.date.available2022-10-05T13:15:08Z
dc.date.created2014-05-20T13:24:53Z
dc.date.issued2009-11-17
dc.identifierCarbohydrate Polymers. Oxford: Elsevier B.V., v. 78, n. 4, p. 789-793, 2009.
dc.identifier0144-8617
dc.identifierhttp://hdl.handle.net/11449/7838
dc.identifier10.1016/j.carbpol.2009.06.017
dc.identifierWOS:000270624200021
dc.identifier2545904877423127
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3884603
dc.description.abstractThe influence of structural characteristics of high amylose cross-linked at different degrees on the release of drugs with important molecular differences, namely sodium diclophenac (SD) and nicotinamide (NI), was assessed in vitro from non-compacted systems. The release profiles were related with classical kinetic mathematical models for better understanding of the release mechanism. An increase in polymer cross-linking degree resulted in longer release time for both drugs, although SD generally was released slower than NI. SD release from samples cross-linked at 2% of basis was driven mainly by Fickian diffusion, while from samples cross-linked at 4% of basis follows anomalous mechanism. Inversely, anomalous mechanism was responsible for NI release from 2% samples and Fickian diffusion from 4% samples. Results suggest that the performance of cross-linked high amylose as excipient for controlled drug release not only depends on cross-linking degree but also is highly influenced by structural characteristics of the drug. (C) 2009 Elsevier Ltd. All rights reserved.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationCarbohydrate Polymers
dc.relation5.158
dc.relation1,428
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectHigh amylose
dc.subjectCross-linking
dc.subjectNicotinamide
dc.subjectSodium diclophenac
dc.subjectRelease mechanism
dc.titleInfluence of phosphated cross-linked high amylose on in vitro release of different drugs
dc.typeArtigo


Este ítem pertenece a la siguiente institución